Related Experiment Video

Updated: Jun 19, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Autophagy in transition from hypertrophic cardiomyopathy to heart failure

Anna Fidziańska, Zofia T Bilińska, Ewa Walczak

    Journal of Electron Microscopy
    |October 3, 2009
    PubMed

    Insights

    Autophagy mechanisms contribute to cardiomyocyte death and heart failure in hypertrophic cardiomyopathy. This study reveals cellular degeneration, including ubiquitin inclusions and abnormal structures, driving heart failure progression.

    Area of Science:

    • Cardiovascular Biology
    • Cellular Pathology
    • Molecular Cardiology

    Background:

    • Investigated endomyocardial biopsy from a patient transitioning from hypertrophic cardiomyopathy (HCM) to heart failure.
    • Examined cellular hallmarks of myocardial degeneration in advanced cardiac disease.

    Discussion:

    • Observed myocyte hypertrophy, atrophy, and significant fibrosis.
    • Identified numerous cardiomyocytes with ubiquitin-positive inclusions, indicative of protein aggregation.
    • Ultrastructural analysis revealed autophagic vacuoles containing cellular debris and abnormal structures like amorphous plaques and tubulofilamentous inclusions.

    Key Insights:

    • Autophagy plays a critical role in the degeneration of myocardial cells.
    • Accumulation of cellular damage and protein aggregates contributes to cardiomyocyte death.
    • These ultrastructural abnormalities are strongly linked to the progression towards heart failure.

    Outlook:

    • Further research into modulating autophagy pathways could offer therapeutic targets for heart failure.
    • Understanding these cellular mechanisms is crucial for developing novel treatments for HCM and heart failure.

    More Related Videos

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

    Published on: June 14, 2016

    Related Concept Videos

    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Autophagy01:27

    Autophagy

    Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
    An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
    Cellular Adaptation II: Hypertrophy01:26

    Cellular Adaptation II: Hypertrophy

    Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...